Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CES1 | P23141 | 2/20 | 0.53 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29029111 | 0.95 | CYP3A4 (0.63) | CYP3A4SMN1; SMN2CA1CA2CES1 | |
| SCHEMBL28837777 | 0.95 | CYP3A4 (0.63) | CYP3A4SMN1; SMN2CA1CA2CES1 | |
| Potassium Ion SCHEMBL12393446 | 0.95 | CYP3A4 (0.63) | CYP3A4SMN1; SMN2CA1CA2CES1 | |
| SCHEMBL6347692 | 0.95 | CA1 (0.63) | CYP3A4SMN1; SMN2CA1CA2CES1 | |
| SCHEMBL28383312 | 0.93 | CA1 (0.61) | CYP3A4SMN1; SMN2CA1CA2CES1 | |
| SCHEMBL8060264 | 0.91 | CA1 (0.59) | CYP3A4SMN1; SMN2CA1CA2CES1 | |
| SCHEMBL8060261 | 0.91 | CA1 (0.59) | CYP3A4SMN1; SMN2CA1CA2CES1 | |
| SCHEMBL8060270 | 0.91 | CA1 (0.59) | CYP3A4SMN1; SMN2CA1CA2CES1 | |
| SCHEMBL21646210 | 0.91 | CA1 (0.59) | CYP3A4SMN1; SMN2CA1CA2CES1 | |
| Zinc Ion SCHEMBL405080 | 0.91 | CA1 (0.59) | CYP3A4SMN1; SMN2CA1CA2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116826208-A | Lithium supplementing positive electrode material, preparation method and application of lithium nitrobenzoate, lithium ion battery and electric equipment | 蜂巢能源科技(无锡)有限公司 | 2023-09-29 | — | — | CN | claimed |
| EP-0947879-B1 | Kit for photographic color developing bath | EASTMAN KODAK CO (US) | 2003-05-21 | — | — | EP | claimed |
| US-6010835-A | Kit for photographic color developing bath | EASTMAN KODAK COMPANY (US) | 2000-01-04 | — | — | US | claimed |
| EP-0947879-A1 | Kit for photographic color developing bath | EASTMAN KODAK COMPANY (US) | 1999-10-06 | — | — | EP | claimed |
| US-20240014395-A1 | NITRO-SUBSITUTED AROMATIC COMPOUNDS FOR USE IN ELECTRODES | YE, ZHIBIN, DR. (CA) | 2024-01-11 | — | — | US | disclosed |
| CN-116826208-A | Lithium supplementing positive electrode material, preparation method and application of lithium nitrobenzoate, lithium ion battery and electric equipment | 蜂巢能源科技(无锡)有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2021108901-A1 | NITRO-SUBSITUTED AROMATIC COMPOUNDS FOR USE IN ELECTRODES | VALORBEC, S.E.C. (CA) | 2021-06-10 | — | — | WO | disclosed |
| EP-0947879-B1 | Kit for photographic color developing bath | EASTMAN KODAK CO (US) | 2003-05-21 | — | — | EP | disclosed |
| US-6010835-A | Kit for photographic color developing bath | EASTMAN KODAK COMPANY (US) | 2000-01-04 | — | — | US | disclosed |
| EP-0947879-A1 | Kit for photographic color developing bath | EASTMAN KODAK COMPANY (US) | 1999-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240014395-A1 | NITRO-SUBSITUTED AROMATIC COMPOUNDS FOR USE IN ELECTRODES | NQO1, NOX4, NES | CYP3A4 106/4885SMN1; SMN2 2264/4885CA1 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.